Trial Profile
Effect of Different Doses of Rosuvastatin Therapy on Regression of Critical Coronary Atherosclerosis in Chinese ACS Patients
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 08 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 22 Apr 2015 New trial record